{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:06:16Z","timestamp":1743825976986,"version":"3.40.3"},"reference-count":111,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2025,3,4]]},"DOI":"10.1080\/13543784.2025.2472410","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T04:40:12Z","timestamp":1740458412000},"page":"131-147","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Mantle cell lymphoma: what clinical progress in the last 5 years?"],"prefix":"10.1080","volume":"34","author":[{"given":"Charbel","family":"Soueidy","sequence":"first","affiliation":[{"name":"Gustave Roussy","place":["Villejuif, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marie","family":"Michot","sequence":"additional","affiliation":[{"name":"Gustave Roussy","place":["Villejuif, France"]},{"name":"Gustave Roussy Cancer Center","place":["Villejuif, France"]},{"name":"Universit\u00e9 Paris-Saclay, Gustave Roussy","place":["Villejuif, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Ribrag","sequence":"additional","affiliation":[{"name":"Gustave Roussy","place":["Villejuif, France"]},{"name":"Gustave Roussy Cancer Center","place":["Villejuif, France"]},{"name":"Universit\u00e9 Paris-Saclay, Gustave Roussy","place":["Villejuif, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx223"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21357"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23608"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25487"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0057"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3149"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015854"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-095331"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.8387"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010757"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58216-2"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153283"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00739-X"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01780"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-370320"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14241"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-01198-2"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-369629"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14480"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13929"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30291-X"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024023944"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0575-9"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014162"},{"key":"e_1_3_4_28_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(24)00184-3","article-title":"Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the european mantle cell lymphoma network","author":"Dreyling M","year":"2024","unstructured":"Dreyling M, Doorduijn J, Gine E, et al. Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the european mantle cell lymphoma network. Lancet. 2024 May 2.","journal-title":"Lancet"},{"key":"e_1_3_4_29_1","volume-title":"Presented at the American Society of Hematology (ASH) Annual Meeting","author":"Dreyling M","year":"2024","unstructured":"Dreyling M. Role of autologous stem cell transplantation in the context of ibrutinib-containing first-line treatment in younger patients with mantle cell lymphoma: results from the randomized triangle trial by the european MCL network [abstract]. Oral and poster abstracts, 623. Mantle cell, follicular, Waldenstrom\u2019s, and other indolent B cell lymphomas: clinical and epidemiological therapies for mantle cell lymphoma. In: Presented at the American Society of Hematology (ASH) Annual Meeting; San Diego, CA; 2024 Dec 7"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00638-0"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02321"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-3883"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00195-2"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13985"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15194759"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00690"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02698"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.881346"},{"key":"e_1_3_4_39_1","volume-title":"Presented at the American Society of Hematology (ASH) Annual Meeting","author":"Fenske TS","year":"2024","unstructured":"Fenske TS. Lack of benefit of autologous hematopoietic cell transplantation (auto-hct) in mantle cell lymphoma (MCL) patients in first complete remission (CR) with undetectable minimal residual disease (uMRD): initial report from the ECOG-ACRIN EA4151 phase 3 randomized trial [abstract]. Late-breaking abstracts session, marquee sessions. In: Presented at the American Society of Hematology (ASH) Annual Meeting; San Diego, CA; 2024 Dec 10"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01294"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200920"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1701769"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01586"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16567"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25783"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30358-6"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024023962"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011271"},{"key":"e_1_3_4_49_1","volume-title":"Presented at the American Society of Hematology (ASH) Annual Meeting","author":"Ladetto M","year":"2024","unstructured":"Ladetto M. Impact of rituximab maintenance added to ibrutinib-containing regimens with and without ASCT in younger, previously untreated MCL patients: an analysis of the triangle data embedded in the multiply project [abstract]. Oral and poster abstracts, 623. Mantle cell, follicular, Waldenstrom\u2019s, and other indolent B cell lymphomas: clinical and epidemiological therapies for mantle cell lymphoma. In: Presented at the American Society of Hematology (ASH) Annual Meeting; San Diego, CA; 2024 Dec 7"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.12.634"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-158656"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00605"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-531327"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009744"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01013-3"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13236089"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.1142"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.191429"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412096"},{"issue":"6","key":"e_1_3_4_61_1","first-page":"705","article-title":"Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study","volume":"24","author":"Robak T","year":"2023","unstructured":"Robak T, Jin J, Pylypenko H, et al. Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study. The Lancet Oncol. 2023;24(6):705\u2013715","journal-title":"The Lancet Oncol"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-859769"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505237"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010606"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009992"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-182374"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201817"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008727"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012424"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-180069"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306220"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00667-4"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.205229"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020211"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12434"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3435"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9500"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22872-z"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0098"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3703"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009168"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018674"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00224-5"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15411"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30018-8"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023388"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-191921"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102221"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4842"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.198812"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70200-0"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0537-5"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011920"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914347"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02370"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006922"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02214"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679134"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021306"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2023.107385"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00072-2"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007512"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-886457"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.224535"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-017-0067-3"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds054"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15721"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2023.2241095"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005289"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20277"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-02006-8"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-00999-8"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022019419"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2025.2472410","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T09:11:37Z","timestamp":1743757897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2025.2472410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,4]]}},"alternative-id":["10.1080\/13543784.2025.2472410"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2025.2472410","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"type":"print","value":"1354-3784"},{"type":"electronic","value":"1744-7658"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-11-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}